These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22941909)

  • 1. Introduction to: current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review.
    Casas LA
    Aesthet Surg J; 2012 Sep; 32(1 Suppl):7S. PubMed ID: 22941909
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Botulinum Toxin Aesthetic Outcomes: Clinical Study vs Real-World Practice.
    Glogau R; Biesman B; Kane M
    JAMA Dermatol; 2015 Nov; 151(11):1177-8. PubMed ID: 26375723
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport).
    Dover JS
    Aesthet Surg J; 2017 May; 37(suppl_1):S1-S3. PubMed ID: 28388716
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
    Kiripolsky MG; Goldman MP
    J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review.
    Maas C; Kane MA; Bucay VW; Allen S; Applebaum DJ; Baumann L; Cox SE; Few JW; Joseph JH; Lorenc ZP; Moradi A; Nestor MS; Schlessinger J; Wortzman M; Lawrence I; Lin X; Nelson D
    Aesthet Surg J; 2012 Sep; 32(1 Suppl):8S-29S. PubMed ID: 22941910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area.
    Mazzuco R; Hexsel D
    J Am Acad Dermatol; 2010 Dec; 63(6):1042-51. PubMed ID: 21093661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
    Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
    J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.
    Frevert J
    Drugs R D; 2015 Mar; 15(1):1-9. PubMed ID: 25559581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aesthetics.
    Poulain B; Trevidic P; Clave M; Aharoni C; Baspeyras M; Bui P; Cartier H; Charavel MH; Coulon P; Dahan S; Dallara JM; Delonca D; Dumas L; Essayagh E; Galatoire O; Georgieu N; Grangier Y; Humbert P; Le Pillouer-Prost A; Mojallal A
    J Drugs Dermatol; 2013 Dec; 12(12):1434-46. PubMed ID: 24301246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glabellar gala.
    Weinberg JM; DeLeo VA
    Cutis; 2002 Jul; 70(1):15. PubMed ID: 12184666
    [No Abstract]   [Full Text] [Related]  

  • 11. Gentlemen, relax: commentary on botulinum toxin in men: a review of relevant anatomy and clinical trial data.
    Jones D
    Dermatol Surg; 2013 Oct; 39(10):1444-5. PubMed ID: 24090255
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on Evolution of Facial Aesthetic Treatment Over Five or More Years.
    Jagdeo J
    Dermatol Surg; 2015 Jul; 41(7):848-9. PubMed ID: 26035045
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosmetic procedures: the possibilities and pitfalls. Botox injections and skin procedures may help your bottom line, but use caution when adding them to your practice.
    Kreimer S
    Med Econ; 2014 Jan; 91(2):61-4. PubMed ID: 25211960
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsurgical treatment of platysma bands with injection of botulinum toxin a revisited.
    Kane MA
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):125S-126S. PubMed ID: 14504493
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products.
    Frevert J
    Drugs R D; 2015 Jun; 15(2):217-8. PubMed ID: 25851380
    [No Abstract]   [Full Text] [Related]  

  • 18. Regarding the treatment of dynamic nasal tip ptosis with botulinum toxin A.
    Ghavami A; Janis JE; Guyuron B
    Plast Reconstr Surg; 2006 Jul; 118(1):263-4. PubMed ID: 16816709
    [No Abstract]   [Full Text] [Related]  

  • 19. Paralyzed by beauty.
    Brun C; Brock-Utne JG
    J Clin Anesth; 2012 Feb; 24(1):77-8. PubMed ID: 22227161
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow up: Botulinum toxin.
    Matarasso A; Chia C;
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):62S-65S. PubMed ID: 14504486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.